All News

Findings from a recent trial show that frontline Opdivo did not improve progression-free survival over chemotherapy in certain patients with lung cancer.

In a recent phase 2 trial, Cabometyx showed longer progression-free survival than Sutent in patients with metastatic kidney cancer.

Survivors and patients with cancer had the opportunity to celebrate alongside their friends, family and medical staff at a recent event in New Jersey.

Judith Paice discusses many of the misconceptions that people have about the use of medical marijuana for patients with cancer.

In October, as we recognize Breast Cancer Awareness Month, let us not forget women with dementia. The mammogram, and related cancer treatment, can be controversial for elderly dementia patients. A care team will help with decision making. In my case, with my mother, we chose to follow-up on a very late diagnosis of breast cancer, with no regrets.

A cohort of patients with ovarian cancer saw survival benefit with niraparib in a recent phase 3 study.

Single-agent Keytruda improved survival rates for a group of patients with lung cancer, according to the results of a recent study presented at the 2016 European Society for Medical Oncology (ESMO) Congress.

Patients with CML who are insured by Medicare are choosing to delay potentially life-saving treatment due to high costs.

When it comes to nutrition, conflicting ideas can often cloud vision.

Knowing the risks of ovarian cancer is extremely important. Peter Dottino discusses the risks, symptoms and management of the disease.

Pelvic intensity-modulated radiation therapy (IMRT) showed a decrease in gastrointestinal toxicity in women with cervical and ovarian cancer, according to a recent study.

The FDA granted Alecensa a breakthrough therapy designation to be used in the frontline setting for some patients with non small-cell lung cancer.

Being cured and being healed are two different things, and one can happen without the other.

Smoking is a major cause of cancer in the United States, but data from a recent study show that talking to a nurse may help some patients quit the habit.

Last night's "In Our Genes: An Evening of Storytelling" was an event that not only raised money for research in BRCA-related cancers, but also aimed to raise the spirits of individuals who have been affected by the gene mutation.

Immunotherapy agents have shown significant promise in treating non-small cell lung cancer (NSCLC) in the second line, but what will their future be in lung cancer's frontline?

Managing emotions can be difficult, but it's important to treasure what you have while you have it.

Today I feel as if I have some unfinished business, though I am not quite sure what it is.

Winson Cheung, M.D., medical oncologist at the British Columbia Cancer Agency in Vancouver, discusses the importance of discussing any immunotherapy-related side effects with health care providers.

Patients, nurses and caregivers to those with cancer, we want to know what kind of exercise works for you, and how you stay motivated. Join us in our upcoming #CureConnect tweet chat!

From promising new therapies to risk prediction, the field of lung cancer care is rapidly evolving. CURE spoke with Corey J. Langer, M.D., to get some updates.

Mita Patel urges patients not to rush to the conclusion that a lump in the breast means cancer. However, it should definitely be checked out by a doctor.

Surgical choices are difficult, but being informed helps make them easier.

A cancer diagnosis can evoke many emotions. It may, indeed, be too much to grasp.

While planning to start her family, Carmen Phaneuf learned that a cancer diagnosis may be in her future. Now, the multiple myeloma survivor urges others to live each day to the fullest.